Advertise on podcast: On Call with Dr. Mary Talley Bowden

Corporate whistleblower John White, a former pharmaceutical marketing executive, details claims of systematic interference with the distribution of monoclonal antibodies (mAbs) as a COVID-19 treatment. White, who volunteered at a Maryland infusion clinic, argues that these therapies—which former NIAID Director Anthony Fauci stated on August 24, 2021, could reduce deaths by up to 85 percent—were deliberately restricted and later withdrawn in favor of oral antivirals from Merck and Pfizer. He frames this as part of a broader pattern that favored vaccination campaigns and certain pharmaceutical products while limiting a tool he and many clinicians viewed as highly effective and well-tolerated. White traces the issue to early pandemic decisions. After President Trump received Regeneron’s REGEN-COV and publicly called it a “cure” in 2020, promising free access for Americans, the FDA’s Emergency Use Authorization limited mAbs to outpatient settings only. This restriction, based on concerns about potential worsening in ventilated patients, prevented use in hospitals where the sickest individuals were concentrated—unlike practices in much of Europe and around the world. Access later became more tightly controlled through government channels rather than direct manufacturer ordering, coinciding with vaccine mandates in September 2021. A key element involved a $142 million Health and Human Services program, contracted through the Army and managed by KPMG, to establish infusion centers in underserved communities. White describes this as initially successful. Yet on November 10, 2021—eleven weeks after Fauci’s statement—the program was pulled. The order cited an anticipated FDA approval of an antiviral pill. The day prior, an order was placed for Merck’s molnupiravir; a week later, a $5 billion order went to Pfizer for Paxlovid, then unauthorized. Early data on molnupiravir’s roughly 50 percent reduction in hospitalization or death later proved overstated, and clinicians largely avoided the oral agents due to efficacy and safety concerns. The most striking sequence, according to White, occurred on December 22, 2021, amid the Omicron surge and the pandemic’s highest U.S. death peak. The FDA issued a memo encouraging greater use of certain mAbs and easing restrictions, while HHS ordered a nationwide shutdown the same day. Paxlovid received its Emergency Use Authorization that day as well. Conflicting agency statements were reconciled the next day in favor of the shutdown. Days later, the CDC revised Omicron prevalence estimates sharply downward from roughly 73 percent to about 20 percent. Subsequent limited reauthorization of products such as sotrovimab proved practically unavailable. An additional incentive to limit monoclonals included a three-month waiting period before vaccination after mAb treatment, which some patients used to delay getting the shot after Biden’s mandates. White, working with a team of lawyers, accountants, and former prosecutors, has filed whistleblower complaints with the Department of Justice antifraud division, HHS Office of Inspector General, Senator Ron Johnson, and Representative Anna Paulina Luna. He contends that if Fauci’s 85 percent figure held, the restrictions may have contributed to a large share of the roughly 1.2 million U.S. COVID deaths. He has sought investigations comparable to the 9/11 Commission and received indications of interest from figures including former Maryland Governor Bob Ehrlich and staff connected to HHS leadership. White maintains the actions constituted coordinated obstruction of a life-saving option that competed with the vaccination narrative, and he urges public contact with congressional oversight figures to compel a full accounting. Ask Rep Luna and Senator Johnson to launch an investigation: Rep Anna Paulina Luna (202) 225-5961. Email Sen Ron Johnson. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Idaho’s Medical Freedom Act and a Federal Court Ruling Leslie Manookian, founder of the Health Freedom Defense Fund, drafted and helped pass Idaho’s Medical Freedom Act into law, a landmark measure passed after an initial gubernatorial veto, signed by Governor Brad Little on April 4, 2025. The statute bars employers, businesses, and public actors from requiring medical interventions—vaccines, tests, masks, pills, devices, or injections—as a condition of ordinary life in Idaho, while still allowing ordinary public-health steps such as sending a sick child home from school or asking someone to wash their hands. This past December, a French-owned daycare in Boise filed a federal lawsuit challenging the law, alleging eight constitutional violations, including interference with freedom of assembly and expression because the facility could not exclude unvaccinated children. The case was filed in federal rather than state court due to claims Idaho’s Medical Freedom Act violates the Constitution. Idaho Attorney General Raul Labrador, who had publicly supported the bill, defended the statute. A federal judge dismissed the complaint with prejudice, meaning it cannot be refiled. Manookian characterized the judge as a moderate Biden appointee who found the plaintiffs’ reading of the law a “gross misinterpretation.” The ruling held that the Act does not silence speech or prevent private expression of views; it only prohibits coercion of medical procedures. Manookian framed the decision as useful precedent for other states. In January 2025 her organization and Stand for Health Freedom launched a 15-group Medical Freedom Act Coalition that includes Americans for Health Freedom. Model legislation and toolkits were circulated. Similar bills were introduced in about a dozen states during the 2026 sessions, often by senior legislators or physicians. Arizona’s version passed both chambers before Governor Katie Hobbs vetoed it. Manookian expected the measure to return in 2027, especially if a more supportive governor is elected. She cited a poll commissioned with Brownstone Institute showing 91 percent of respondents across parties favored informed consent for medical choices, including vaccination, and 87 percent wanted medical freedom written into law. Our discussion then turned to federal agencies. Manookian argued the CDC lacks statutory authority under the Public Health Service Act to issue vaccine recommendations that shape individual medical decisions or to practice “shared clinical decision making.” She compared the situation to earlier litigation against the FDA over ivermectin statements and to her own successful 2022 challenge to the federal transportation mask mandate. She contended that no childhood vaccine on the CDC schedule has undergone a proper placebo-controlled safety study and that state statutes often incorporate the federal schedule, giving recommendations the practical force of law. She also warned of hundreds of mRNA products in development and urged state legislatures, not federal agencies, to set health policy. We both stressed grassroots work: contacting legislators in the off-season, joining newsletters, attending local meetings, and supporting allied groups. Manookian presented the Idaho ruling and the multi-state campaign as evidence that medical-freedom legislation can survive court review and that public support is broader than some pollsters claim. Follow Leslie Manookian and the Health Freedom Defense Fund on X. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Neuroscientist Dr. Kevin McCairn joins us for our 4th update on a promising treatment for those disabled from the COVID shots. He and Dr. Cato have now treated more than 65 patients with severe injuries, and tonight, one of my patients, 22-year-old Jack and his mother Karrie, share their experience and Jack’s response to the 4-week protocol he went through in Japan. The core protocol combines immune-adsorption apheresis (DFPP), performed through a central line, with daily IV high-dose stem-cell growth factors. The team aims for four weekly cycles of five treatment days. A central line, rather than a peripheral IV, is used because filtering blood closer to the brain more efficiently removes autoantibodies and protein aggregates that impair circulation and oxygen delivery. Growth factors appear synergistic, helping the body recover after the filtration step. Results have been better than he anticipated, given the severity and duration of these patients’ symptoms. Roughly ten to twelve patients showed little improvement, often in the presence of other illnesses. Another group improved only modestly; many of them were later found to have previously undetected cerebrospinal-fluid leaks. A sizable remainder, including Jack, experienced marked relief. McCairn described the overall pattern as encouraging yet still early, noting that some patients may need repeat sessions months or years later. Jack’s account illustrated both the severity of symptoms and the speed of change after treatment. Once an active teenager, he developed unexplained depression, crushing fatigue, abdominal pain, extreme weight swings, swollen purple extremities, and blood-work anomalies that conventional labs could not reconcile. Cardiac imaging was abnormal. Multiple physicians prescribed antidepressants, suggested drug use or infection, or diagnosed conditions later ruled out. After years of emergency-room visits and specialist referrals, the family traveled to Japan in July for a 28-day course. The first two weeks were physically and emotionally taxing, especially the placement of neck catheters. By the third cycle Jack walked thousands of steps and reported returning energy and clearer thinking. Back home he has lost more than thirty pounds of inflammatory swelling, resumed light exercise, and maintains a largely carnivore diet; even one processed meal produced two days of relapse. His mother Karrie emphasized that diet and completion of the full protocol mattered. She also stressed the value of an accompanying advocate, given language barriers and the intensity of daily procedures. McCairn and the family contrasted Japan’s established use of these techniques for neurological conditions with the regulatory, legal, and insurance obstacles that keep similar care scarce in the United States. Screening now includes myelography because CSF leaks appear far more often in this cohort than in the general population and seem to blunt treatment response. Dr. McCairn has been inundated with requests for help but is limited by equipment that cannot process samples quickly and is in need of funds for better analytic equipment to study blood samples systematically. He has instructions on how to send a sample on his website , but due to demand, results could take months. While Jack’s recovery is evidence that targeted intervention can help some of the most severely affected patients, larger studies, longer follow-up, and regulatory change would be required before such care could become routine. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

AMERICANS FOR HEALTH FREEDOM | FOR IMMEDIATE RELEASE September 21, 2026 Media Contact: Trevor Fitzgibbon 704-775-0487, [email protected] Americans for Health Freedom Tucker Carlson, Massie and Greene Join Doctors Warning Trump: Ban mRNA Shots or Lose the MAHA Vote Coalition of physicians, scientists and vaccine-injured families — with more than 63 million combined social-media followers — tells the White House and HHS Secretary Kennedy the health-freedom bloc will back challengers unless mRNA products are pulled from the market WASHINGTON — Tucker Carlson, Rep. Thomas Massie, former Rep. Marjorie Taylor Greene and more than 100 physicians, scientists and parents of vaccine-injured children have delivered a formal warning to President Donald J. Trump and Health and Human Services Secretary Robert F. Kennedy Jr.: remove mRNA COVID-19 shots and related gene-therapy products from the U.S. market or lose the Make America Healthy Again vote. The letter, organized by Americans for Health Freedom and a network of community physicians, says continued inaction on what signatories call the centerpiece of the health-freedom agenda will drive that bloc toward electoral challengers in the midterms and in 2028. The organizers put the coalition’s combined social-media reach at more than 63 million followers. “The removal of mRNA shots has been the central goal of the MAHA and health-freedom agenda, yet you have not taken decisive action despite credible evidence of harm,” the signatories wrote. “If you continue to ignore the centerpiece of our policy agenda — removing all mRNA products covered by PREP Act emergency declarations entirely from the market — you will pay a political price.” What the Letter Says Is Incomplete The coalition argues that current HHS, CDC and FDA policy undercuts the health-freedom platform the administration campaigned on. The letter cites, among other objections: • Continued administration of COVID mRNA shots to more than 50 million Americans this year, including an estimated 7 million children, which the authors say proceeds without studies showing prevention of hospitalization or death and amid data they say document severe harms, including pediatric deaths acknowledged by the FDA; • The appointment of Erica Schwartz to lead the CDC after she told the Senate that mRNA technology is safe and effective; • Approval of a new mRNA influenza shot that, the letter says, was not tested against a true placebo, lacks long-term safety data and did not measure hospitalization or death; • A $1.24 billion HHS contract award to Pfizer for future mRNA products, including products for children; • No meaningful federal assistance for people the coalition says were injured by mRNA shots; • The CDC’s failure to publish current cancer statistics amid claims of rising incidence the signatories link to the shots; and • Failure to enforce manufacturers’ contractual duty to report adverse events to VAERS. The letter also criticizes an Aug. 10, 2026, executive order that reduced the childhood schedule from 17 to 11 vaccine types while elevating pneumococcal and HPV shots into a “universal core recommendation” and adopting “shared decision-making” language the authors call constitutionally corrosive. Signatories cite Merck’s reported $50 million Gardasil settlement with plaintiffs who alleged autoimmunity. Evidence Cited and Six Demands The authors write that more than 4,550 peer-reviewed publications, Pfizer documents obtained in litigation by attorney Aaron Siri, VAERS and V-safe data, and foreign-government datasets already document “catastrophic levels of deaths and serious injuries,” including reproductive harm they describe as an approximately 400 percent increase in miscarriage rates. They say pregnancy remains listed as a high-risk category in revised FDA policy even after CDC recommendation language changed, and that the American Academy of Pediatrics continues to recommend mRNA shots for infants. A Children’s Health Defense citizen petition seeking to relabel Pfizer and Moderna COVID-19 products as EUA countermeasures rather than fully approved vaccines has been pending at HHS since Dec. 8, 2025, and has drawn more than 104,000 public comments, the letter says. The PREP Act emergency declaration remains in force through Dec. 31, 2029. The coalition asks the president and the secretary to take six near-term steps: 1. Ban mRNA and gene therapy–derived technologies for all vaccines, citing what signatories call demonstrated failure on safety, efficacy and disease prevention after more than four years and billions of doses; 2. Terminate the PREP Act declaration for COVID injections on the grounds that no emergency exists; 3. Recommend that Congress repeal the PREP Act entirely because of constitutional conflicts; 4. Ban pharmaceutical direct-to-consumer advertising, as every country except the United States and New Zealand already does; 5. Review and revise HHS policies the letter says create perverse incentives for medical coercion, including vaccination; and 6. End conflicts of interest at the CDC, FDA, NIH and NIAID. Political Warning Signatories say they will recruit candidates at the state level and support challengers and sponsors of related federal legislation. They describe the MAHA and health-freedom vote as a historic swing bloc without which neither major party could have prevailed. Lead signatory Mary Talley Bowden, M.D., of Americans for Health Freedom, the Independent Medical Alliance and the Vaccine Safety Research Foundation, is joined by Independent Medical Alliance President and CMO Joseph Varon, M.D.; McCullough Foundation President Peter A. McCullough, M.D.; cardiologist Aseem Malhotra, M.D.; Robert W. Malone, M.D., M.S.; Jill Glasspool Malone, Ph.D.; Ryan Cole, M.D.; Sean Troxclair, M.D., Louisiana’s deputy surgeon general; Vaccine Safety Research Foundation founder Steven Kirsch; evolutionary biologist Bret Weinstein, Ph.D.; investigator Sasha Latypova; comedian Jimmy Dore; Tucker Carlson; former Rep. Marjorie Taylor Greene; Minnesota State Rep. Shane Mekeland; parents of vaccine-injured children including Allen and Taylor Martin and Dan Hartman; React19 Co-Chair Joel Wallskog, M.D.; and more than 100 additional physicians, nurses and advocates listed on the published letter. The letter was inspired by medical-freedom leaders including former pharmaceutical executive Sasha Latypova and Jack Jasper and Andy Schmitt of Paradox Press. The full letter and growing list of signatories are posted at americansforhealthfreedom.org/letter-to-kennedy. ### About Americans for Health Freedom Americans for Health Freedom is a national advocacy organization working with physicians, scientists and grassroots medical-freedom groups to restore informed consent, end liability shields for emergency medical products, and remove what it regards as unsafe genetic-vaccine platforms from the U.S. market. Media note: Interview requests for Dr. Mary Talley Bowden and other signatories may be directed through Americans for Health Freedom. The letter is available for reprint with attribution. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Board-certified psychiatrist Dr. Joseph Witt-Doerring discusses his specialized focus on adverse reactions to psychiatric medications and safe de-prescribing, using the high-profile Lindsay Clancy case as a timely illustration. Witt-Doerring, who has worked in clinical practice, for Johnson & Johnson, and at the FDA, argues that conventional psychiatry often oversimplifies mental distress as chemical imbalances requiring indefinite drug treatment. His approach emphasizes common-sense interventions—gradual medication reduction, accountability for diet, physical activity, and lifestyle—helping many patients regain energy and motivation that long-term drugs can suppress. Witt-Doerring reports that for roughly 80 percent of cases involving anxiety, depression, or insomnia, patients can discontinue medications without major issues. More complex conditions such as bipolar disorder or schizophrenia present greater challenges, and some individuals elect to remain on treatment. He notes a growing network of clinicians, including Mark Horowitz in the UK and participants in deprescribing mentorship programs, who share this holistic orientation. The conversation centered on Lindsay Clancy, a Massachusetts mother charged with killing her three young children in early 2023. Initially, many viewed the act as pure evil warranting imprisonment. Witt-Doerring contends the medical record supports a finding of not guilty by reason of insanity due to medication-induced psychosis. After her third child, Clancy experienced postpartum depression and life stresses. Telemedicine providers prescribed Zoloft, an SSRI; she developed severe insomnia, the dose was doubled, symptoms worsened, and it was stopped. She was later placed on Prozac, then Seroquel, and eventually amitriptyline, with the dose increased the day before the tragedy. In a short period she was exposed to approximately 11 medications. Drug labels explicitly warn that antidepressants can precipitate mania and psychosis. Clancy later reported command auditory hallucinations. Collateral evidence includes text messages in which she described the drugs damaging her brain and making her feel worse, disclosure of intrusive homicidal thoughts to family weeks earlier, and forensic analysis of her computer searches for medication side effects. Family, friends, colleagues, and her nanny described her as a loving mother with no history of violence, substance abuse, or relational breakdown—the typical motives in filicide cases. The prosecution’s theories of psychopathy or “altruistic filicide” appear inconsistent with this background. Witt-Doerring highlights parallel malpractice concerns over continued antidepressant prescribing despite clear worsening. He cites legal precedents. In the Donald Schell case, a man with a prior adverse reaction to Prozac was prescribed Paxil and, within days, killed his wife, daughter, and granddaughter before taking his own life; a jury found the manufacturer liable for failure to warn. In Canada, David Carmichael killed his son while experiencing Paxil-induced delusions and was not prosecuted for murder after authorities accepted the drug-induced psychosis explanation. Witt-Doerring underscores broader risks: roughly 17 percent of Americans take SSRIs and about 5 percent are on multiple psychiatric medications. Adverse behavioral effects are more pronounced in younger patients, whose nervous systems continue maturing into the late twenties. High-risk windows include initiation, dose increases, and abrupt discontinuation. SSRI withdrawal, long minimized as mild and self-limiting, proves severe for a substantial minority—surveys indicate that around one-third cannot discontinue because of intolerable symptoms. He advocates stronger informed consent, clinician education on deprescribing, and greater attention to physical health. Obesity, ultra-processed diets, and sedentary lifestyles contribute heavily to anxiety, depression, and insomnia; treating the body improves the mind. The Clancy case, while tragic, illustrates how rapid polypharmacy and ignored warning signs can produce catastrophic outcomes and why safer, more individualized psychiatric practice is urgently needed. Follow Dr. Josef on X and visit his clinic website here. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Attorney Brian Festa of We The Patriots USA, a pro bono firm focused on medical and religious freedom cases, outlines ongoing legal battles over states’ elimination of religious exemptions to school vaccination requirements. These efforts highlight tensions between public health mandates and First Amendment protections for religious liberty, particularly in private and religious educational settings. Festa describes the case of three Amish community schools in New York, which faced fines exceeding $150,000 for continuing to accept religious exemptions after the state repealed them in 2019. New York, like California, Connecticut, and Maine, abolished such exemptions for all schools—public, private, and parochial. West Virginia effectively bars them as well. The Amish schools, operating as private religious institutions, allowed families to opt out based on sincerely held beliefs opposing vaccination. After losing at the district court and initially at the Second Circuit, the case was remanded by the Supreme Court in light of Mahmoud v. Taylor (2025), which affirmed parents’ rights to opt children out of certain school curricula on religious grounds, and related rulings extending similar principles to public health contexts. Despite this, the Second Circuit again dismissed the challenge, distinguishing vaccination mandates as less invasive of religious freedom than curricular content—a distinction Festa criticizes, noting that vaccination effects are irreversible while classroom teaching can be countered at home. We The Patriots is litigating a nearly identical case involving Milford Christian Church and its Little Eagles Preschool in Connecticut. After Connecticut eliminated religious exemptions in 2021, the preschool continued honoring them. State inspectors threatened closure unless unvaccinated children were either vaccinated or expelled. A federal lawsuit filed in 2023 reached oral argument at the Second Circuit in April; a decision is expected imminently and is likely to follow the Amish precedent. Festa anticipates an adverse ruling, after which the firm plans to petition the Supreme Court. A parallel suit was filed in July against a public school district in Turner, Maine, on behalf of an eighth-grader whose parents seek a religious exemption. These cases position the organization to challenge exemptions losses across multiple federal circuits. Festa explains the strategic focus on religious free exercise rather than a broader bodily autonomy claim. Citing Dobbs v. Jackson Women’s Health Organization, which rejected an unenumerated constitutional right to bodily autonomy in the abortion context, he noted that courts have not recognized a general right against compelled medical interventions outside narrow settings. Religious objections often center on the historical use of aborted fetal cell lines in vaccine development and testing, as well as other ingredients or manufacturing processes that conflict with faith-based principles. A Supreme Court victory could establish nationwide precedent protecting parental rights to religious opt-outs, whether limited to religious schools or applied more broadly to all educational settings. Such a ruling would endure far longer than temporary political or executive measures. Collectively, these cases represent a multi-year campaign to restore religious exemptions and affirm parental authority. Supreme Court review offers the most durable path to protecting these liberties for current and future generations, given the lasting nature of constitutional precedent. We the Patriots is a pro-bono, non-profit legal firm focusing on medical and religious freedom cases. Register for their upcoming Vaccine Safety Awareness Marathon: Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Maternal-fetal medicine specialist Dr. James Thorp discussed newly revealed text messages involving Dr. Anthony Fauci and concerns about COVID shots in pregnancy. Thorp, who has long spoken out on the topic and published related research, framed the messages as evidence that officials recognized early risks yet proceeded with aggressive promotion to pregnant women. Thorp noted that pregnancy is highly sensitive to inflammation, which can disrupt embryonic development, placentation, and lead to miscarriage, fetal death, and other complications. He referenced historical disasters such as thalidomide and diethylstilbestrol as reminders of the need for caution with unstudied substances. In his view, authorities knew the vaccines were inflammatory and associated with miscarriages but withheld the information, consistent with broader patterns of downplaying vaccine signals. Thorp offered two strategic reasons for targeting pregnant women. First, women make the majority of healthcare decisions for families across the lifespan; securing their acceptance would influence broader uptake. Second, as the most vulnerable population, their vaccination would signal safety and necessity to everyone else. He described the overall effort as a public-relations campaign led by figures such as Mark Weber at HHS, involving coordination with medical organizations, hospitals, colleges, and state boards. Professionally, Thorp faced pressure after speaking out. In September 2021, the American Board of Obstetrics and Gynecology (ABOG) emailed thousands of obstetricians, warning that failure to follow official guidelines could result in loss of licensure and board certification. Thorp responded with a detailed letter citing peer-reviewed studies, VAERS analyses, and adverse outcome data. He reported no further action against him and continued annual certification. Through a FOIA request filed with his wife, attorney Maggie Thorp, they obtained records indicating financial arrangements between HHS/CDC and the American College of Obstetricians and Gynecologists (ACOG), which then influenced related societies. Thorp argued that physicians were effectively given talking points rather than independent clinical judgment. Timeline details included the December 2020 vaccine rollout, initial statements that use in pregnancy would be voluntary, rapid uptake among healthcare workers (many pregnant), and subsequent organizational endorsements by mid-2021 culminating in the ABOG threat. Pregnant women were not exempted from workplace mandates. Thorp sharply criticized the April 2021 New England Journal of Medicine paper by Shimabukuro et al. and accompanying commentary, that contradicted VAERS data suggesting an approximately 82% miscarriage rate among completed early pregnancies—similar to figures derived from Pfizer’s post-marketing report of roughly 81% among cases with known outcomes. He also highlighted high overall casualty numbers in that short Pfizer document and questioned data-handling practices such as counting vaccinated status only after 14 days. Clinically, Thorp described observing no unusual patterns in 2020 among the thousands of high-risk pregnancies he managed, followed by sharp increases after vaccine rollout: severe menstrual irregularities across age groups, infertility, later miscarriages with heavy bleeding, fetal malformations (including rare conditions like diaphragmatic hernia appearing in clusters), cervical insufficiency, placental abnormalities, growth restriction, thrombotic events, preterm delivery, and higher neonatal intensive-care admissions. Colleagues largely remained silent, he said, after seeing professional consequences for those who raised concerns. He attributed institutional compliance partly to substantial federal funding received by hospital systems under agreements that limited disclosure. Thorp has documented these issues in his book Sacrifice: How the Deadliest Vaccine in History Targeted the Most Vulnerable, with proceeds supporting vaccine-injured individuals, and has a new Christian devotional forthcoming. The interview underscores his contention that early official awareness of risks to pregnant women was subordinated to a broader vaccination campaign, with lasting clinical and institutional effects. Follow Dr. Thorp on X @jathorpmfm and drjamesthorp.com. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Dr. My Le Trinh, a general practitioner in Sydney with more than 27 years in practice, faced an abrupt and prolonged professional crisis beginning September 27, 2021. Until that point she had maintained a spotless professional record, but on a single day, she was notified of two complaints lodged hours apart through the same portal. One originated from a junior doctor at a hospital concerning a COVID patient Trinh had treated remotely with ivermectin; the patient’s condition worsened and was admitted. The intern later told Trinh she had acted on instructions from a superior, an associate professor and toxicologist at Westmead Hospital. The second complaint came from an individual identifying as “John Smith,” who alleged concern for a friend’s health after an ivermectin prescription and claimed Trinh was an “anti-vaxxer” promoting alternative COVID treatments online. Contact details for this complainant proved invalid. The prescription in question belonged to a family member of Trinh’s; she had left it at a pharmacy after supplies ran short, and the pharmacy later handed it to the Australian Health Practitioner Regulation Agency (AHPRA). Australian authorities had severely restricted ivermectin prescribing by general practitioners, limiting it to specialists for approved indications and citing concerns about supply for conditions such as scabies in Aboriginal communities. Hydroxychloroquine had faced earlier and stricter limits. Official guidance for diagnosed COVID patients emphasized isolation at home under daily health-officer checks, with only paracetamol recommended and pulse-oximeter monitoring; patients were directed to hospital if their condition worsened. Trinh, having researched early treatments and followed clinicians associated with groups such as the COVID Medical Network, chose to offer ivermectin-based regimens via telehealth to patients confined by health orders. Regulators treated the dual notifications as grounds for an emergency hearing, determining she posed a risk to the public and suspending her registration the same day. Nearly five years later she remains unable to practice or provide medical advice. She pursued appeals, a judicial review, and proceedings through the tribunal and higher courts, only to encounter procedural complications when arguments were altered under pressure. Concurrently the Health Care Complaints Commission investigated and prosecuted her for unsatisfactory professional conduct and professional misconduct, including failure to surrender records of 20–30 patients—records she withheld on independent legal advice that the request lacked proper authority. In mid-2025 she was found guilty at the first stage of proceedings; the second stage, concerning sanctions, remains pending while she has filed a fresh appeal and judicial review in the Supreme Court. Trinh acknowledges she could have submitted and ended the matter more quickly. She has instead continued the fight, citing the need to defend the principle that doctors may exercise clinical judgment, including legitimate off-label prescribing once recognized even by health ministers early in the pandemic. The experience has been deeply traumatic, leaving her uncertain whether she will ever return to practice. Her account illustrates the intensity of regulatory responses to early-treatment approaches in Australia, the speed with which suspension can occur, and the protracted, costly legal processes that follow when a practitioner contests the outcome. Follow Dr. Trinh on X @myletrinh123 and donate to her legal fund here. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Dr. Kevin McCairn and patient Ken Evans joined me to discuss a promising intervention for severe COVID-19 vaccine injuries. Conducted from Japan, where McCairn and colleagues treat patients, the conversation highlights the debilitating effects of vaccine-induced amyloid formation and a novel therapeutic approach offering dramatic recoveries. McCairn, who has treated approximately 25 patients, describes vaccine injuries linked to abnormal amyloid and mis-folded proteins, often triggered by spike protein. These cause widespread microclots, autoimmune responses, brain fog, extreme fatigue, heart irregularities, neuropathy, and organ damage. Many patients arrive after years of misdiagnosis and ineffective treatments, having spent hundreds of thousands of dollars. Evans, a former rugby player from Houston, exemplifies this struggle. Vaccinated in March 2021, he rapidly developed symptoms: skyrocketing spike antibodies (over 18,000), low B cells, liver dysfunction, endocrine chaos, autoimmune encephalitis, and malignant pericarditis visible on X-rays as a large inflamed sac around the heart. Conventional tests (cardiac MRI, stress tests) appeared normal, and doctors dismissed vaccine causation, sometimes bordering on malpractice. Thyroid removal worsened his condition. He endured ER visits with heart rates spiking to 190 bpm, fainting, blood in multiple sites, and profound brain fog that stripped him of emotion and clarity. “I was dying,” Evans recalls. “I couldn’t get out of bed.” The Japan protocol involves jugular-vein dual filtration apheresis using specialized canisters to remove autoantibodies, amyloids, and misfolded proteins directly from cerebral outflow, combined with stem cell growth factors (SGF) derived from dental pulp to promote regeneration and inhibit further clotting. Unlike peripheral vein methods, this targets neurovascular injury. Evans underwent four weeks of treatment. After the first filtration, his cognitive clarity returned. Post-second session, the pressure in his heart and panic lifted. X-rays three weeks later showed near-complete resolution of pericarditis. Spike antibodies dropped 25%, and he regained 85% function—able to laugh, parent, and live normally, though managing residual Hashimoto’s. “I have my life back,” he says. Chest X-Rays of Ken Evans before and after treatment: Many others report rapid relief from brain fog and fatigue, with spectacular turnarounds even in severe cases. Nurse Lindsay, previously housebound for years, is now able to run. Recovery is slower with extensive brain damage but generally positive. Challenges remain. Treatment costs are high, unavailable in the U.S. due to regulatory hurdles, and patients often exhaust resources first. McCairn notes emerging hydrogel-like plasma changes in samples, raising concerns about broader contamination risks. He stresses autoantibodies and molecular mimicry drive much pathology beyond persistent spike. While not a universal cure, the intervention achieves clinical significance for many. Evans’ story underscores medical gaslighting yet offers hope. As advocates push for U.S. access and recognition, this protocol demonstrates that targeted removal of pathological proteins paired with regenerative support can reverse what seemed irreversible damage. For countless injured individuals, it represents not just treatment, but restored humanity. If you are interested in having your blood tested for amyloid, go to Synpatek Labs for further instructions. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Since the rollout of COVID shots in 2021, embalmers worldwide have reported a startling new phenomenon: unusual white, fibrous clots unlike any seen in decades of practice. These rubbery, calamari-like structures, often solid and stretchy, have appeared in 20-30% of corpses according to multiple surveys, primarily in individuals who received mRNA vaccines. Retired U.S. Air Force Major Tom Haviland, a data analyst and engineer, has become a leading voice documenting this issue after his own professional stand against vaccine mandates. Haviland, fired in 2021 from his $165,000 defense contracting role at Wright-Patterson Air Force Base for refusing the experimental mRNA shot, turned his analytical skills toward this mystery. Inspired by the 2022 documentary Died Suddenly, he contacted the Ohio Embalmers Association. Vice President Woody Wilson confirmed seeing the clots, corroborating accounts from embalmers who first noticed them roughly six months after vaccine deployment. Haviland and collaborator Laura Kasner launched global surveys of embalmers from 2022 to 2025. Results consistently showed 66-83% of respondents observing these clots in 20-30% of cases, with sharp increases in the 36-50 age group—aligning with excess mortality and disability data from analysts like Edward Dowd. Scientific teams, including Australian organic chemist Greg Harrison, have analyzed the clots using advanced techniques. Normal clotting involves fibrinogen converting to fibrin in balanced alpha, beta, and gamma chains, forming smooth, plasmin-degradable structures. These abnormal clots show a distorted 9:4:1 ratio, with high phosphorus, sulfur, and sometimes tin, low iron, magnesium, and potassium. Researchers hypothesize that spike protein—whether from infection or vaccine—and phospholipid nanoparticles phosphorylate and hijack fibrinogen, creating misfolded, amyloid-like polymers resistant to breakdown. Thioflavin T staining lights them up green under UV, confirming amyloid properties. Scanning electron microscopy reveals twisted, nodular fibers unlike normal “spaghetti-like” fibrin. Alarmingly, these clots appear not only in corpses but in living patients. Endovascular specialist Dr. Mahana Basheeret reported extracting them via catheter from legs, hearts, and other vessels in his Jacksonville cath lab. Similar reports from a UK whistleblower describe 3-10 such clots weekly, almost exclusively in vaccinated individuals, with severity increasing by dose count. Standard clot-busters like tPA fail; physical removal is required. Radiologists struggle to detect them as they mold to vessel walls. Microclots resembling “coffee grounds” also clog capillaries, impairing oxygen exchange.Official response has been minimal. Haviland shared survey data with FDA, CDC, and NIH annually since 2023, including before an advisory meeting, yet received no substantive action. Some doctors faced pressure to cease communication. Funeral associations largely remain silent, despite member concerns. Patient surveys (over 1,400 responses) mirror CDC V-safe data, showing post-2021 surges in leg, lung, brain, and heart clots. This vascular amyloidosis represents a visible, testable signal amid broader debates on vaccine side effects. While spike from infection may contribute in rare cases, persistence of mRNA-driven production offers a plausible driver for ongoing cases years later. Protocols like nattokinase, bromelain, and curcumin aim to address spike, with advanced filtration showing promise. As embalmers continue annual conventions and data collection, independent science must prioritize rigorous autopsy, imaging, and blood supply studies. Transparency and further investigation are essential to understand and mitigate this persistent issue. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Dr. Terri DeNeui, DNP, APRN, ACNP-BC, founder of Evexias and a leading expert in peptide and hormone therapies, discusses regulatory challenges with peptides and the importance of clinical supervision. Insulin and GLP-1 agonists are peptides with an established role in medicine. Now we are seeing broader applications of peptides used for inflammation, autoimmune conditions, muscle preservation, sleep, and tissue repair. The FDA’s 2022 decision to remove several peptides from the compounding safety list disrupted access for patients and clinicians. This shift pushed many toward gray-market sources, often labeled “research only,” raising serious safety concerns regarding purity, potency, and sourcing. Recent enforcement actions have shut down non-compliant suppliers shipping across state lines. DeNeui emphasizes that reputable compounding pharmacies adhering to FDA-inspected facilities and good manufacturing practices remain viable in certain states, but patients should avoid unverified online vendors. Underground products lack proper testing and clinician oversight, posing risks of contamination or inconsistent dosing. Growth hormone-stimulating peptides like CJC-1295 and ipamorelin attract teenagers via social media for muscle building and performance. DeNeui strongly cautions against this. Healthy adolescents with normal growth and puberty do not need them; exogenous interference can disrupt natural hormone balance, potentially stunting growth, elevating prolactin (causing gynecomastia), or causing pituitary issues. These compounds are better suited for age-related sarcopenia, injury recovery (e.g., Lisfranc fractures under medical supervision), or immune support in adults via peptides like Thymosin Alpha-1 and BPC-157. Proper cycling and clinician guidance are essential, as peptides act briefly and require tailored protocols. GLP-1 medications demonstrate strong efficacy for obesity and type 2 diabetes but demand careful management. Compounded versions are more affordable and allow micro-dosing to minimize side effects, though muscle loss remains a concern—up to 40% of weight lost can be lean mass without adequate protein and monitoring. Adverse events, including rare severe cases like pancreatitis, underscore the need for baseline assessments and experienced providers. DeNeui favors starting with semaglutide or tirzepatide from trusted sources. Hormone replacement, particularly subcutaneous bioidentical pellets (estrogen and testosterone), offers sustained release for three to six months. Unlike synthetic options such as Premarin (derived from mare urine), bioidentical or biosimilar hormones more closely mimic the body’s molecules. Pellet hormone therapy, used since the 1930s, supports mood, libido, energy, muscle maintenance, and overall quality of life, especially as testosterone declines in women post-childbearing. Progesterone is typically taken orally and necessary when taking estrogen to protect the uterus. Individual dosing accounts for age, activity, and hormone levels; side effects like unwanted hair growth are manageable. Urine metabolite testing (e.g., DUTCH) and GI mapping provide deeper insights into hormone processing and gut health, which influences conditions like PCOS, endometriosis, and fibroids. Both peptides and hormones offer powerful tools when used responsibly under trained clinicians. They are not shortcuts for lifestyle deficits but complements to nutrition, sleep, exercise, and stress management. As regulation evolves and research advances, prioritizing safety, evidence, and personalized care will maximize benefits while minimizing risks. Professional guidance remains non-negotiable for these potent therapies. Follow Terri DeNeui on X and learn more with her book “Hormone Havoc.” Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

The rollout of modified mRNA COVID-19 shots raises profound questions about long-term safety, including their potential persistence in the body and impact on the blood supply. Many individuals, particularly those unvaccinated or concerned about adverse reactions, now seek greater control over blood transfusions during planned surgeries or emergencies. Organizations like Safe Blood address this by matching recipients with donors who share similar vaccination status preferences, reviving practices once considered routine and noncontroversial. Safe Blood, founded in September 2021 by George Della Pietra in Switzerland, operates internationally with a strong U.S. presence across all 50 states. Vice President Clinton Ohlers, who heads media relations, explains that the group facilitates directed donations—where friends, family, or community members donate specifically for a patient—and supports autologous donations, in which patients donate their own blood in advance when time allows the body to regenerate red blood cells. This service proves especially vital when patients require multiple units for complex procedures like C-sections, aneurysm repairs, or cancer surgeries, exceeding what one person can safely provide alone. Concerns stem from early observations by European naturopaths and doctors who examined blood under magnification and noted anomalies in vaccinated individuals, sometimes resembling patterns seen in late-stage cancer patients, even among those without symptoms. These findings coincided with a reported 522% increase in blood-related illness claims in the UK from 2021 to 2022. While mainstream health authorities maintain that mRNA shots do not transmit via blood and that vaccinated donors pose no added risk, questions persist about lingering spike protein, potential DNA fragments, and biodistribution effects documented in some studies. A high-profile case involved a Texas patient at Baylor St. Luke’s whose wife—a universal donor—and friends were denied the opportunity to donate directed blood for his surgery. The hospital also resisted autologous donation despite sufficient lead time. Such denials highlight tensions between patient autonomy and institutional policies. The FDA issued guidance on October 23, 2023, cautioning that directed donations based on characteristics like vaccination status lack scientific support and may carry higher infectious disease risks than the general supply. Critics argue this relies on a 2013 Dorsey et al. study from an earlier era dominated by AIDS-related fears. That study initially showed higher infection markers in directed donations (often from first-time donors), but after adjusting for repeat versus new donors, the risk difference largely disappeared or even favored directed donations in some metrics. Opponents claim the FDA’s interpretation misrepresents the data to discourage patient choice, echoing past controversies over information suppression during the pandemic. The U.S. blood industry generates substantial revenue—estimated in the tens of billions annually—and the country exports a significant portion of plasma-derived products, accounting for roughly 2.65% of total exports and supplying about 70% of global needs in some categories. Blood banks often separate whole blood into components (packed red cells, platelets, plasma) for efficiency and reformulate as needed, a process that may generate more revenue than simple directed whole-blood transfers. Large organizations like the American Red Cross and others have opposed legislation protecting directed and autologous donations, citing supply chain concerns and invoking the FDA statement. Hospitals contract exclusively with one blood bank, creating bottlenecks when policies conflict. In response, over a dozen states have introduced bills to safeguard patient rights to autologous or directed donations and, in some cases, require labeling or separation of blood by donor vaccination status. Idaho advanced such legislation with near-unanimous support after testimony revealed local barriers, including denials even for autologous blood. Similar efforts in Texas nearly passed but faced procedural hurdles, while bills in Tennessee, Kentucky, and elsewhere continue. Proponents emphasize that one’s own blood or that from known healthy donors was historically the safest option and should not suddenly become restricted. They also highlight alternatives like Cell Saver technology, which recycles a patient’s own blood during surgery (common in open-heart procedures), though hospitals rarely offer it proactively. Demand for Safe Blood’s matching services is rising, driven by resistance from hospitals and blood banks. The organization does not collect or store blood itself to avoid heavy regulation; instead, it connects compatible donors and recipients for timely, fresh transfers coordinated through physicians and hospital blood banks. Membership is open on a sliding scale, with donor volunteers (unvaccinated individuals willing to help) providing critical support at no cost. Ultimately, this debate transcends blood logistics. It concerns medical freedom, transparency, and the right to informed consent in an era of novel biotechnologies whose full effects remain under study. While regulatory bodies assert the blood supply’s safety based on standard infectious disease screening (HIV, hepatitis, etc.), growing patient advocacy seeks empirical verification and choice—especially in non-emergencies. As states deliberate legislation, the core principle endures: the safest blood is often one’s own or from trusted sources, and policies should prioritize patient well-being over institutional convenience or industry flow. Safe Blood and similar initiatives represent a grassroots effort to restore that autonomy, ensuring future generations inherit a blood supply that respects individual risk assessments. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

In the darkest days of the COVID-19 pandemic, Dr. Ron Elfenbein emerged as a true American hero. An emergency medicine physician and operator of Maryland’s largest monoclonal antibody infusion network, he treated more than 100,000 patients across eight sites with the most effective treatment we had for COVID. Patients arrived on death’s door; within hours, many were dramatically improved. Dr. Elfenbein scaled his practice from six employees to over 300, working around the clock for two years while forgoing time with his own family. His efforts earned him citations from the Maryland governor and state legislature, plus “Person of the Year” honors from the state medical society—even after his indictment. Yet today this same doctor faces up to 50 years in federal prison. The reason? He dared to speak out when the Biden administration pulled monoclonal antibodies in December 2021, a move he argued would cost lives. Appearing on Fox News and Newsmax, Dr. Elfenbein publicly warned that the effective treatment was being sacrificed to protect the emergency-use authorization of COVID vaccines. Federal law, he noted, bars EUAs for vaccines when alternatives exist. Four months later, without warning or subpoena, the Department of Justice indicted him on five counts of healthcare fraud for “upcoding”—billing a Level 4 evaluation-and-management code instead of Level 3, a difference averaging roughly $50 per claim. The total alleged overpayment across the five charts reviewed: $250. The case was built on five patient charts out of more than 100,000. No professional coder was consulted before indictment; government lawyers simply declared the codes fraudulent. Two independent expert coders later reviewed hundreds of charts and found no fraud—one was the former president of the ethics committee of the American Association of Professional Coders, the other a DOJ trainer who hunts fraud for a living. Even the American Medical Association and the Association of American Physicians and Surgeons filed amicus briefs defending Dr. Elfenbein, noting that he followed the very coding rules the AMA itself wrote. After a three-week trial, a jury convicted him. But Chief Judge of Maryland overturned the verdict in an unprecedented 93-page opinion, declaring there was literally “no evidence” of a crime and that the government’s case should never have been brought. The judge called it a “shoot first and ask questions later” prosecution. The Biden DOJ appealed on its final day in office, forcing a new trial scheduled for August 2026. Dr. Elfenbein now asks the Trump administration’s weaponization task force—established by Attorney General Pam Bondi—to review his case as a protected whistleblower. Former U.S. Attorney Rod Rosenstein publicly called the prosecution baseless. Meanwhile, Dr. Elfenbein’s legal bills have reached millions; he drives a Hyundai and relies on his wife, a pediatric oncologist, to keep the family afloat. This is not a story about $250 in disputed billing. It is a cautionary tale of government retaliation against a doctor who saved lives and told the truth. The case must be dropped—not as a favor, but as simple justice. Americans who risked everything to fight a pandemic should not spend the rest of their lives fighting their own government. Visit dropthecase.com to support Dr. Elfenbein and help ensure this injustice ends. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

As a trained anesthesiologist and pain medicine specialist, Dr. Heidi Klessig had a pivotal experience as a resident that shattered her assumptions about the definition of brain death and organ harvesting. During night call, Dr. Klessig was assigned to anesthetize a young man declared brain dead after a motorcycle accident for organ procurement. She expected a corpse-like patient but found him warm, pink, with stable vital signs and occasional movements—indistinguishable from other ICU patients. When she proposed a paralyzing agent to prevent movement and fentanyl to stabilize hemodynamics (to protect organs), her attending asked if she planned to administer a drug to block consciousness. Stunned, she replied that he was dead. The attending’s cool suggestion to give it “just in case” planted seeds of doubt. The patient responded to surgical incision, bone sawing, and organ manipulation with typical hemodynamic changes, requiring standard anesthesia. This experience haunted Dr. Klessig, prompting her to examine primary sources. She later authored The Brain Death Fallacy, arguing that brain death is not equivalent to biological death but a utilitarian redefinition enabling organ procurement. Historical Context and the Harvard Redefinition For millennia, death was recognized by the irreversible cessation of heartbeat, breathing, and the passage of time—signs observable without medical technology. Traditions like wakes ensured certainty. In 1968, shortly after Christiaan Barnard’s heart transplants, a Harvard ad hoc committee proposed “irreversible coma” as a new criterion for death. Their JAMA paper, lacking scientific references, described patients as “desperately injured” and a “burden,” justifying the change on utilitarian grounds: freeing ICU beds and resolving controversies over taking organs from comatose individuals. The committee did not claim these patients were biologically dead; it redefined them as such by fiat. This bypassed the “dead donor rule”—a moral precept requiring donors to be dead before organ removal and not killed by the process. By declaring certain comatose patients dead, procurement could proceed legally while the body remained biologically alive, warm, and perfused. Scientific and Philosophical Flaws Dr. Klessig highlights that brain death is often a prognosis, not a diagnosis of death. A key 1970s neuropathology study of 26 brains declared brain dead under stricter criteria found 10 normal and fewer than half showing diffuse destruction. The authors concluded it predicted possible death, not confirmed it. Subsequent cases, including a boy (known as TK) who lived 20 years post-declaration with no brain tissue at autopsy (only scar tissue), demonstrate that biological life can persist. Modern guidelines (e.g., 2023 American Academy of Neurology) rely on a clinical bedside exam: unresponsiveness, no motor response to pain, absent brainstem reflexes, and an apnea test. These are subjective. EEG is no longer required, despite 20% of diagnosed cases showing brain waves; over half retain hypothalamic function (regulating temperature, blood pressure, and awareness). Legal definitions demand irreversible cessation of all brain functions, creating inconsistencies that have prompted failed attempts to revise the Uniform Determination of Death Act. Patients like Jenny Heyman, declared brain dead yet inwardly aware and able to recover with attentive care, underscore that unresponsiveness does not equal unconsciousness or death. Dr. Klessig notes the public receives no informed consent about these debates when checking “organ donor” at the DMV. Financial and Systemic Pressures Hospitals must report potential donors to organ procurement organizations (OPOs) under CMS rules for Medicare/Medicaid funding. Transplants generate massive revenue—one set of organs (heart, lungs, liver, kidneys, etc.) can yield over $8 million in billable charges, contributing to a $60+ billion industry. Cases like TJ Hoover, who showed purposeful movement and survived after being prepared for harvest, illustrate pressure on staff, and practices like controlled donation after circulatory death (DCD) and normothermic regional perfusion (NRP) further blur lines. In DCD, life support is withdrawn from non-brain-dead patients with poor prognoses; a short “no-touch” period follows cardiac arrest before procurement. Reports, including Misty Hawkins (who gasped and had a beating heart upon incision), show risks of intervening on still-living individuals. NRP involves clamping brain circulation to declare brain death mid-procedure while resuscitating other organs—ethically controversial. Internationally, issues are graver: China’s state-linked trafficking from prisoners of conscience and cartel activity in Mexico exploit vulnerable populations. Ethical Imperative and Protections Dr. Klessig distinguishes ethical living donation (e.g., kidney from a relative or stranger) from deceased donation reliant on contested definitions. She argues society has sacrificed progress in neurological care by writing off “hard cases” as donors rather than treating them. To protect oneself: Avoid registering as an organ donor, as it is legally binding and OPOs have sued families. Use resources like respectforhumanlife.com for refusal documents, healthcare power of attorney, and wallet cards. Families should ask detailed questions and seek second opinions. Dr. Klessig’s account, rooted in clinical experience and historical analysis, urges informed consent and reevaluation. Changing definitions does not alter biological reality. True respect for human life demands transparency, rigorous science, and ethical alternatives to practices that risk treating the living as dead. Follow Dr. Klessig on X and on YouTube. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe

Dr. Mollie James, a board-certified surgeon and critical care specialist, treated critically ill patients during the height of the pandemic, often facing ethical dilemmas when standard treatments were restricted. Her refusal to receive the COVID shot and her commitment to providing what she believed was the best available care led to her dismissal from three ICUs during the Delta wave. Rather than retreating, Dr. James founded The James Clinic, a concierge functional medicine practice born from these experiences, emphasizing integrative, patient-centered approaches over conventional models. Currently operating primarily in St. Louis (Chesterfield Valley), with additional locations in Iowa and an upcoming expansion to Des Moines, the clinic focuses on restoring cellular health, particularly through mitochondrial function. Dr. James highlights MitoRegen™ (also called Mitochondrial Reboot Protocol), an innovative intravenous therapy that replicates the body’s natural pulsatile insulin signaling. Studies dating back to the 1970s identified microscopic insulin oscillations from the pancreas to the liver, triggering enzymes that enhance mitochondrial efficiency and ATP production. Illness disrupts this signal, causing mitochondria to shift away from glucose utilization and lose energy output. This therapy uses a specialized pump to deliver tiny, pulsatile doses of regular insulin (typically 10-15 units total over three hours) intravenously, mimicking natural bursts every six minutes. Patients often carb-load beforehand, with blood sugar monitored every 15 minutes to prevent hypoglycemia as awakened mitochondria consume glucose. Research cited in her practice shows a 30% increase in ATP production, with profound effects on conditions like neuropathy—published data indicate 90-95% resolution after 12 treatments. Dr. James shares a striking case of a team member whose chemo-induced burning pain vanished within an hour of starting treatment. The approach views mitochondria as the “root of the root” problem in chronic illness. Exhausted cells enter survival mode, halting repair and detox processes encoded in DNA. By boosting energy, the therapy empowers innate healing, potentially reversing issues like dementia, stroke damage, fatty liver, and cirrhosis. For vaccine-injured patients—whom Dr. James believes suffered mitochondrial toxicity from spike protein—the treatment holds promise, though many affected individuals face financial and trust barriers five years later. Complementing this are advanced diagnostics like GlycoCheck, which visualizes the glycocalyx (arterial lining damaged by COVID, contributing to clots, strokes, and heart attacks) via sublingual microscopy, paired with Revasca, a seaweed-based supplement for repair. Other offerings include EBOO (extracorporeal blood oxygenation and ozonation) for filtration of cytokines, spike protein remnants, and debris, plus ozone, oxygen, UV/light therapy; soft hyperbaric chambers for neurologic and wound issues; PRP injections; peptides; and foundational supports like CoQ10, L-carnitine, red light therapy, and detox protocols emphasizing sleep, movement, sunlight, clean diet, and hydration. Dr. James advocates a holistic concierge model with monthly follow-ups, troubleshooting, and objective testing (e.g., VO2 max) to track progress. She practices telemedicine widely but recommends in-person initial visits for testing. Despite her clean record and exoneration from prior board scrutiny, Dr. James faces unexplained delays in obtaining a Texas medical license—over 15 months since applying in November of the prior year. She suspects irregularities, noting Texas’s streamlined processes for foreign-trained physicians amid shortages, yet her references (sent multiple times) went unlocated. Through JamesClinic.com, Dr. James offers hope for those with complex, energy-depleted conditions, prioritizing root-cause restoration over symptom masking. Her work represents a shift toward empowering cellular resilience in an era of rising chronic illness. Follow Dr. James on X and on Instagram. Get full access to Dangerous Misinformation at drbowden.substack.com/subscribe